CSI Market
Sign In | Register

Atyr Pharma Inc (ATYR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATYR Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Atyr Pharma Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ATYR/balance-sheets
https://api.csimarket.com/api/v1/companies/ATYR/fundamentals
https://api.csimarket.com/api/v1/companies/ATYR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent13.14
Available-for-sale Securities, Debt Securities, Current MA35.61
Cash & Short-term Investments48.00
Other Receivables, Net, Current0.58
Prepaid Expense, Current AS0.83
Total Current Assets50.16
Equipment/Property/Plant Net3.38
Other Assets, Noncurrent6.27
Restricted Cash Noncurrent2.24
Operating Lease Right Of Use Asset5.52
Total Assets59.81
Liabilities
Accounts Payable, Current AC3.90
Accrued Liabilities, Current AC11.19
Other Liabilities, Current1.37
Total Current Liabilities16.46
Total Long-term Debt0.00
Other liabilities, Noncurrent9.36
Operating Lease Liability Current0.84
Operating Lease Liability Noncurrent10.31
Total Liabilities25.82
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock679.50
Retained Earnings / Accumulated Deficit-645.53
Accumulated Other Comprehensive Income-0.09
Other Equity-0.09
Common Stockholder's Equity34.17
Non-controlling interests & other-0.19
Total Stockholder's Equity33.98
Liabilities & Stockholder's Equity59.81
4 historic quarters locked

Sign in to unlock the full Atyr Pharma Inc balance sheet history.

Sign In Create Free Account

About Atyr Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001339970-26-000081

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI